Avoro Capital Advisors LLC: holdings and changes

Number 80 of the top 100 funds by copy return. Avoro Capital Advisors LLC reported 30 US stocks worth $9.7B for the quarter ending 2026-09-30 and changed 5 new, 0 added, 5 trimmed and 1 sold since 2026-06-30.

Copy return, 4 quarters+37.5%
US 500, same time+14.5%
Size$9.7B
Stocks30

Holdings

StockChangeWeightValueShares
UTHR
United Therapeutics Corp
15.41%$1.5B2,755,555
ASND
Ascendis Pharma A/S
11.87%$1.2B5,050,000
KRYS
Krystal Biotech INC
9.91%$961M2,888,888
ARGX
Argenx Se
9.89%$959M1,000,000
MDGL
Madrigal Pharmaceuticals INC
9.53%$924M1,833,333
KYMR
Kymera Therapeutics INC
8.62%$836M7,474,747
ARWR
Arrowhead Pharmaceuticals, INC.
TRIM -3%7.43%$720M11,000,000
RVMD
Revolution Medicines INC
TRIM -7%4.54%$440M2,145,000
CYTK
Cytokinetics INC.
3.33%$323M4,900,000
DFTX
Definium Therapeutics INC
2.77%$268M7,050,000
GPCR
Structure Therapeutics INC
2.12%$205M6,555,555
XENE
Xenon Pharmaceuticals INC
TRIM -5%2.11%$204M5,500,000
VERA
Vera Therapeutics INC
1.88%$182M5,635,000
QURE
Uniqure Nv
1.68%$162M6,727,777
CELC
Celcuity INC
TRIM -56%1.23%$119M1,500,000
TSHA
Taysha Gene Therapies INC Com Shs
1.20%$116M23,888,888
OCUL
Ocular Therapeutix INC
0.98%$95M12,380,300
DMRA
Damora Therapeutics INC Com Shs
BUY0.83%$80M3,783,000
COAG
Hemab Therapeutics Hldgs INC
0.60%$58M1,892,372
VRDN
Viridian Therapeutics INC
0.53%$52M2,500,000
SEPN
Septerna INC
0.52%$51M1,300,000
ABVX
Abivax Sa-Adr
BUY0.50%$48M488,000
SCTX
Scribe Therapeutics INC
BUY0.49%$48M2,598,973
SENSEI BIOTHER
Sensei Biotherapeutics INC
0.43%$42M1,410,000
GHRS
Gh Research PLC
0.43%$42M1,770,000
Biohaven Pharm
Biohaven Pharmaceutical Holding Co. LTD
BUY0.38%$37M2,750,000
AVTX
Avalo Therapeutics INC
0.38%$36M2,377,777
BRVE
Braveheart Bio INC
BUY0.26%$25M1,255,000
AADI BIOSCIENC
Aadi Biosciences INC
0.11%$11M2,849,402
LXEO
Lexeo Therapeutics INC
TRIM -65%0.02%$2M525,000
GALECTO INC
Galecto INC
SELL0%was $98M0

Copy return each quarter

HeldFund copyUS 500
2023-06-30 → 2023-09-30-5.7%-3.6%
2023-09-30 → 2023-12-31+17.6%+11.2%
2024-03-31 → 2024-06-30+0.5%+4.0%
2024-06-30 → 2024-09-30+2.9%+5.4%
2024-09-30 → 2024-12-31-1.8%+2.1%
2024-12-31 → 2025-03-31-7.6%-4.6%
2025-03-31 → 2025-06-30-3.9%+10.5%
2025-06-30 → 2025-09-30+36.9%+7.8%
2025-09-30 → 2025-12-31+24.2%+2.4%
2025-12-31 → 2026-03-31+3.9%-4.6%
2026-03-31 → 2026-06-30+20.3%+14.8%
2026-06-30 → 2026-09-30-11.5%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP